Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Click here to browse AJSM online!

Sign In to gain access to subscriptions and/or personal tools.
Clinical Pediatrics
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Lazar, L.
Right arrow Articles by Merlob, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lazar, L.
Right arrow Articles by Merlob, P.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Phototherapy for Neonatal Nonhemolytic Hyperbilirubinemia

Analysis of Rebound and Indications for Discontinuing Therapy

Leora Lazar, M.D.

Department of Neonatology Beilinson Medical Center Petah Tikva, Israel Sackler School of Medicine Tel Aviv University Tel Aviv, Israel

Aviva Litwin, M.D.

Department of Neonatology Beilinson Medical Center Petah Tikva, Israel Sackler School of Medicine Tel Aviv University Tel Aviv, Israel

Paul Merlob, M.D.

Department of Neonatology Beilinson Medical Center Petah Tikva, Israel Sackler School of Medicine Tel Aviv University Tel Aviv, Israel

Phototherapy, an effective treatment for neonatal indirect hyperbilirubinemia, has guidelines for its initiation but none for its discontinuation. In our study, phototherapy was begun at a mean age of 90 hours in 28 full-term and 30 preterm infants with indirect nonhemolytic hyperbilirubinemia. After three days, phototherapy was halted at a mean bilirubin concentration of 13.0 ± 0.7 mg/dL in term and 10.7 ± 1.2 mg/dL in preterm infants, levels higher than those used by other investigators. Bilirubin rebound then occurred at a mean of 12.5 hours to a level of 0.86 ± 1.0 mg/dL in term and at a mean of 14.1 hours to a level of 0.83 ± 0.56 mg/dL in preterm infants. No complications were observed nor was there a need for reinstitution of phototherapy. Based on these data, discontinuation of phototherapy at higher bilirubin concentrations and earlier home discharge than previously described appear harmless for both term and preterm neonates.

Clinical Pediatrics, Vol. 32, No. 5, 264-267 (1993)
DOI: 10.1177/000992289303200502
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?